
Danny Hong
Examiner (ID: 2374, Phone: (571)270-5107 , Office: P/3727 )
| Most Active Art Unit | 3727 |
| Art Unit(s) | 3723, 3727 |
| Total Applications | 485 |
| Issued Applications | 270 |
| Pending Applications | 0 |
| Abandoned Applications | 215 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19430751
[patent_doc_number] => 20240299249
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-12
[patent_title] => Liquid Filled Capsule with Two Phase Liquid Fill
[patent_app_type] => utility
[patent_app_number] => 18/573077
[patent_app_country] => US
[patent_app_date] => 2022-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5144
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18573077
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/573077 | Liquid Filled Capsule with Two Phase Liquid Fill | Jun 23, 2022 | Pending |
Array
(
[id] => 18314083
[patent_doc_number] => 11628143
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2023-04-18
[patent_title] => Tablet for oral suspension
[patent_app_type] => utility
[patent_app_number] => 17/840382
[patent_app_country] => US
[patent_app_date] => 2022-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8678
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17840382
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/840382 | Tablet for oral suspension | Jun 13, 2022 | Issued |
Array
(
[id] => 18091229
[patent_doc_number] => 20220409570
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-29
[patent_title] => COMPOSITION OF N-PALMITOYL-ETHANOLAMIDE AND BAICALEIN IN CO-MICRONIZED FORM
[patent_app_type] => utility
[patent_app_number] => 17/836902
[patent_app_country] => US
[patent_app_date] => 2022-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3423
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17836902
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/836902 | COMPOSITION OF N-PALMITOYL-ETHANOLAMIDE AND BAICALEIN IN CO-MICRONIZED FORM | Jun 8, 2022 | Pending |
Array
(
[id] => 17881244
[patent_doc_number] => 20220296721
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-22
[patent_title] => MEMBRANE FOR STICKING TO LIVING ORGANISM, AND METHOD FOR PRODUCING SAME
[patent_app_type] => utility
[patent_app_number] => 17/824473
[patent_app_country] => US
[patent_app_date] => 2022-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13779
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 107
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17824473
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/824473 | MEMBRANE FOR STICKING TO LIVING ORGANISM, AND METHOD FOR PRODUCING SAME | May 24, 2022 | Abandoned |
Array
(
[id] => 17850392
[patent_doc_number] => 20220280433
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-08
[patent_title] => STABLE LOW DIGESTIVE ENZYME CONTENT FORMULATION
[patent_app_type] => utility
[patent_app_number] => 17/750648
[patent_app_country] => US
[patent_app_date] => 2022-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12081
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17750648
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/750648 | Stable low digestive enzyme content formulation | May 22, 2022 | Issued |
Array
(
[id] => 18018866
[patent_doc_number] => 20220370365
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-24
[patent_title] => SOLID PREPARATION CONTAINING TAFAMIDIS AND METHOD FOR PRODUCING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/747276
[patent_app_country] => US
[patent_app_date] => 2022-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3315
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17747276
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/747276 | SOLID PREPARATION CONTAINING TAFAMIDIS AND METHOD FOR PRODUCING THE SAME | May 17, 2022 | Abandoned |
Array
(
[id] => 18243273
[patent_doc_number] => 20230075584
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-09
[patent_title] => INTRANASAL ADMINISTRATION OF GLUTAMATE CARBOXYPEPTIDASE (GCP-II) INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 17/737229
[patent_app_country] => US
[patent_app_date] => 2022-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11794
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17737229
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/737229 | INTRANASAL ADMINISTRATION OF GLUTAMATE CARBOXYPEPTIDASE (GCP-II) INHIBITORS | May 4, 2022 | Pending |
Array
(
[id] => 17944327
[patent_doc_number] => 20220331344
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-20
[patent_title] => ORAL FORMULATIONS OF PSYCHOTROPIC MACROFUNGUS BOTANICAL EXTRACTS WITH MOUTHFEEL EXPERIENCE ENHANCERS
[patent_app_type] => utility
[patent_app_number] => 17/704206
[patent_app_country] => US
[patent_app_date] => 2022-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17109
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17704206
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/704206 | ORAL FORMULATIONS OF PSYCHOTROPIC MACROFUNGUS BOTANICAL EXTRACTS WITH MOUTHFEEL EXPERIENCE ENHANCERS | Mar 24, 2022 | Abandoned |
Array
(
[id] => 17734914
[patent_doc_number] => 20220220373
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-14
[patent_title] => FLUORESCENT PROBES FOR MONOACYLGLYCEROL LIPASE (MAGL)
[patent_app_type] => utility
[patent_app_number] => 17/700987
[patent_app_country] => US
[patent_app_date] => 2022-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8658
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17700987
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/700987 | FLUORESCENT PROBES FOR MONOACYLGLYCEROL LIPASE (MAGL) | Mar 21, 2022 | Pending |
Array
(
[id] => 17719199
[patent_doc_number] => 20220211918
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-07
[patent_title] => USE OF NANOCRYSTALS FOR DRUG DELIVERY FROM A BALLOON
[patent_app_type] => utility
[patent_app_number] => 17/699265
[patent_app_country] => US
[patent_app_date] => 2022-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3980
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17699265
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/699265 | USE OF NANOCRYSTALS FOR DRUG DELIVERY FROM A BALLOON | Mar 20, 2022 | Pending |
Array
(
[id] => 19075382
[patent_doc_number] => 11944726
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-04-02
[patent_title] => Method for fabrication of additively manufactured, self-gelling structures and their use
[patent_app_type] => utility
[patent_app_number] => 17/698787
[patent_app_country] => US
[patent_app_date] => 2022-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 16
[patent_no_of_words] => 10053
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17698787
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/698787 | Method for fabrication of additively manufactured, self-gelling structures and their use | Mar 17, 2022 | Issued |
Array
(
[id] => 17702723
[patent_doc_number] => 20220202729
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-30
[patent_title] => NEW DELAYED RELEASE COMPOSITION FOR PERORAL ADMINISTRATION
[patent_app_type] => utility
[patent_app_number] => 17/696997
[patent_app_country] => US
[patent_app_date] => 2022-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16079
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17696997
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/696997 | Delayed release composition for peroral administration | Mar 16, 2022 | Issued |
Array
(
[id] => 17889774
[patent_doc_number] => 11452721
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-09-27
[patent_title] => Formulations of pimavanserin
[patent_app_type] => utility
[patent_app_number] => 17/693830
[patent_app_country] => US
[patent_app_date] => 2022-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 5
[patent_no_of_words] => 10545
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17693830
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/693830 | Formulations of pimavanserin | Mar 13, 2022 | Issued |
Array
(
[id] => 19578807
[patent_doc_number] => 12144889
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-11-19
[patent_title] => Methods of treating allergic conjunctivitis
[patent_app_type] => utility
[patent_app_number] => 17/673331
[patent_app_country] => US
[patent_app_date] => 2022-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 12
[patent_no_of_words] => 27857
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 106
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17673331
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/673331 | Methods of treating allergic conjunctivitis | Feb 15, 2022 | Issued |
Array
(
[id] => 19947149
[patent_doc_number] => 12318487
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-06-03
[patent_title] => Solid tablet dosage form of ridinilazole
[patent_app_type] => utility
[patent_app_number] => 17/576242
[patent_app_country] => US
[patent_app_date] => 2022-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 21
[patent_no_of_words] => 17324
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17576242
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/576242 | Solid tablet dosage form of ridinilazole | Jan 13, 2022 | Issued |
Array
(
[id] => 18946995
[patent_doc_number] => 11890267
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-02-06
[patent_title] => Benzonatate modified release solid tablets and capsules
[patent_app_type] => utility
[patent_app_number] => 17/573333
[patent_app_country] => US
[patent_app_date] => 2022-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 20501
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 106
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17573333
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/573333 | Benzonatate modified release solid tablets and capsules | Jan 10, 2022 | Issued |
Array
(
[id] => 17561682
[patent_doc_number] => 20220125831
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-28
[patent_title] => REGENERATIVE CO2 TREATMENT SYSTEM AND METHOD
[patent_app_type] => utility
[patent_app_number] => 17/572025
[patent_app_country] => US
[patent_app_date] => 2022-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5856
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17572025
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/572025 | REGENERATIVE CO2 TREATMENT SYSTEM AND METHOD | Jan 9, 2022 | Pending |
Array
(
[id] => 18953781
[patent_doc_number] => 20240042108
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-08
[patent_title] => Orthopedic Internal Fixation Implanted Medical Device
[patent_app_type] => utility
[patent_app_number] => 18/267708
[patent_app_country] => US
[patent_app_date] => 2021-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5126
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18267708
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/267708 | Orthopedic Internal Fixation Implanted Medical Device | Dec 27, 2021 | Pending |
Array
(
[id] => 18921254
[patent_doc_number] => 20240024258
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-25
[patent_title] => TREATMENT REGIMEN FOR ONCHYOMYCOSIS USING ALLYLAMINE ANTIFUNGAL COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 18/256446
[patent_app_country] => US
[patent_app_date] => 2021-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11784
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -50
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18256446
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/256446 | TREATMENT REGIMEN FOR ONCHYOMYCOSIS USING ALLYLAMINE ANTIFUNGAL COMPOSITIONS | Dec 6, 2021 | Pending |
Array
(
[id] => 18953563
[patent_doc_number] => 20240041890
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-08
[patent_title] => ANTI-HAIR-LOSS COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 18/255027
[patent_app_country] => US
[patent_app_date] => 2021-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11077
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -37
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18255027
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/255027 | ANTI-HAIR-LOSS COMPOSITION | Nov 24, 2021 | Pending |